Journal articleUrol Oncol · June 2026
INTRODUCTION: Enfortumab vedotin plus pembrolizumab (EVP) has emerged as frontline treatment for patients with advanced urothelial carcinoma. Consolidative surgery can be offered to select patients with surgically resectable disease following EVP; however, ...
Full textLink to itemCite
Journal articleUrol Oncol · May 2026
PURPOSE: To investigate the incidence and determine the risk factors associated with acute kidney injury (AKI) following radical nephrectomy with inferior vena cava (IVC) thrombectomy. METHODS: We retrospectively reviewed the records of patients who underw ...
Full textLink to itemCite